🔎 Trials Near Me

Home › Sezary Syndrome

Sezary Syndrome clinical trials recruiting in the U.S.

13 studies for Sezary Syndrome are recruiting participants at sites across the United States.

Cities with the most studies

By state

Recently updated studies

A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06854653

Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT04930653

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 21, 2026 · NCT07192471

Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma

RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT03011814

Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 1, 2026 · NCT04256018

Registry of Older Patients With Cancer

RecruitingObservational study
Ages 65 and older · All sexes · Updated Jun 29, 2026 · NCT01137825

A Registry for People With T-cell Lymphoma

RecruitingObservational study
All ages · All sexes · Updated May 20, 2026 · NCT05978141

Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 3, 2026 · NCT03587844

Extracorporeal Photopheresis in Sezary Syndrome

RecruitingObservational study
Ages 18 to 100 · All sexes · Updated Dec 30, 2025 · NCT05157581

Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

RecruitingObservational study
Ages 18 and older · All sexes · Updated Dec 30, 2025 · NCT00177268

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

RecruitingObservational study
Ages 18 to 120 · All sexes · Updated Oct 27, 2025 · NCT01137643

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 22, 2025 · NCT04234048

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.